Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Deciphera Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

               
Security Type   

Security

Class

Title

  

Fee

Calculation

Rule

  

Amount

Registered (1)

  

Proposed

Maximum

Offering

Price Per

Share (2)

  

Maximum

Aggregate

Offering

Price (2)

  

Fee

Rate

  

Amount of

Registration

Fee (2)

               
Equity  

2017 Stock Option and Incentive Plan

Common Stock, $0.01 par value per share

   457(h)   2,705,494 shares (3)   $17.33   $46,886,211.02   .0001102   $5,166.86
               
Equity  

2017 Employee Stock Purchase Plan

Common Stock, $0.01 par value per share

   457(h)   400,000 shares (4)   $17.33   $6,932,000.00   .0001102   $763.91
               
Equity  

2022 Inducement Plan, as amended

Common Stock, $0.01 par value per share

   457(h)   270,000 shares (5)   $17.33   $4,679,100.00   .0001102   $515.64
         
Total Offering Amounts     $58,497,311.02     $6,446.40
         
Total Fee Offsets         $0
         
Net Fee Due               $6,446.40

 

(1)

Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock which become issuable under the above-named plans by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock. Pursuant to Rule 416(c) under the Securities Act, this Registration Statement shall also cover an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plans described herein.

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act, and based on $17.33, the average of the high and low sale prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on February 3, 2023.

(3)

Consists of 2,705,494 shares of Common Stock that may become issuable under the Registrant’s 2017 Stock Option and Incentive Plan pursuant to its terms.

(4)

Consists of 400,000 shares of Common Stock that may become issuable under the Registrant’s 2017 Employee Stock Purchase Plan pursuant to its terms.

(5)

Consists of 270,000 shares of Common Stock that may become issuable under the Registrant’s 2022 Inducement Plan, as amended, pursuant to its terms.